Differential neuronal and astrocytic expression of transforming growth factor beta isoforms in rat hippocampus following transient forebrain ischemia

Molecular Brain Research

Volumn 40, Issue 1, 1996, Pages 1-14

  Knuckey, N W ^a,c   Finch, P ^a,b   Palm, D E ^a,c   Primiano, M J ^a,c   Johanson, C E ^a,c   Flanders, K C ^a,e   Thompson, N L ^a,d  

^a SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c Brown University Program in Neurosurgery   (United States)

^d BROWN UNIVERSITY   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Brain injury; Choroid plexus; GFAP; Growth factor; Hybridization; In situ; Microglia

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; LECTIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; EMBRYO; FOREBRAIN; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICROGLIA; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; RAT; TRANSIENT ISCHEMIC ATTACK;

ANIMALIA; GRIFFONIA SIMPLICIFOLIA;

EID: 0030221814     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(96)00016-2     Document Type: Article

References (69)

1. [1] Auer, R.N., Jensen, M.L. and Whishaw, I.Q., Neurobehavioral deficit due to ischemic brain damage limited to half of the CA 1 sector of the hippocampus, J. Neurosci., 9 (1989) 1641-1647.
2. [2] Baghdassarian, D., Toru-Delbauffe, D., Gavaret, J.M. and Pierre, M., Effects of transforming growth factor-β1 on the extracellular matrix and cytoskeleton of cultured astrocytes, Glia, 7 (1993) 193-202.
3. [3] Chalzonitis, A.J., Kalberg, D.R., Twardzik, R.W., Morrison, W. and Kessler, A., Transforming growth factor β has neurotrophic actions on sensory neurons in vitro and is synergistic with nerve growth factor, Dev. Biol., 152 (1992) 121-132.
4. [4] Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J. and Rutter, W.J., Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease, Biochemistry, 18 (1979) 5294-5299.
5. [5] Choi, D.W., Cerebral hypoxia: some new approaches and unanswered questions, J. Neurosci., 10 (1990) 2493-2501.
6. [6] Church, G.M. and Gilbert, W., Genomic sequencing, Proc. Natl. Acad. Sci. USA, 81 (1984) 1991-1995.
7. [7] Constam, D.B., Philipp, J., Malipiero, U.V., ten Dijke, P., Schachner, M. and Fontana, A., Differential expression of transforming growth factor-β1, -β2, and -β3 by glioblastoma cells, astrocytes, and microglia, J. Immunol., 148 (1992) 1404-1410.
8. [8] Da Cunha, A., Jefferson, J.A., Jackson, R.W. and Vitkovic, L.,. Glial cell-specific mechanisms of TGF-β1 induction by IL-1 in cerebral cortex, J. Neuroimmunol., 42 (1993) 71-85.
9. [9] Da Cunha, A. and Vitkovic, L., Transforming growth factor-beta 1 (TGF-beta 1) expression and regulation in rat cortical astrocytes, J. Neuroimmunol., 36 (1992) 157-169.
10. [10] Davis, H.P., Tribuna, J., Pulsinelli, W.A. and Volpe, B.T., Reference and working memory of rats following hippocampal damage induced by transient forebrain ischemia, Physiol. Behav., 37 (1986) 387-392.
11. [11] Dawson, V.L., Dawson, T.M., London, E.D. and Bredt, D.S., Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures, Proc. Natl. Acad. Sci. USA, 88 (1991) 6368-6371.
12. [12] Denhez, F., Lafyatis, R., Kondaiah, P., Roberts, A.B. and Sporn, M.B., Cloning by polymerase chain reaction of a new mouse TGF-beta, mTGF-beta 3, Growth Factors, 3 (1990) 139-146.
13. [13] Endoh, M., Pulsinelli, W.A. and Wagner, J.A., Transient global ischemia induces dynamic changes in the expression of bFGF and the FGF receptor, Mol. Brain Res., 22 (1994) 76-88.
14. [14] Finch, C.E., Laping, N.J., Morgan, T.E., Nichols, N.R. and Pasinetti, G.M., TGF-β1 is an organizer of responses to neurodegeneration. J. Cell. Biochem., 53 (1993) 314-322.
15. [15] Flanders, K.C., Cissel, D.S., Mullen, L.T., Danielpour, D., Sporn, M.B. and Roberts, A.B., Antibodies to transforming growth factor-beta 2 peptides: specific detection of TGF-beta 2 in immunoassays, Growth Factors, 3 (1990) 45-52.
16. [16] Flanders, K.C., Ludecke, G, Engels, S., Cissel, D.S., Roberts, A.B., Kondaiah, P., Lafyatis, R., Sporn, M.B. and Unsicker, K., Localization and actions of transforming growth factor-βs in the embryonic nervous system, Development, 113 (1991) 183-191.
17. [17] Flanders, K.C., Lüdecke, G., Renzing, J., Hamm, C., Cissel, D.S. and Unsicker, K., Effects of TGF-βs and bFGF on astroglial cell growth and gene expression in vitro, Mol. Cell Neurosci., 4 (1993) 406-417.
18. [18] Flanders, K.C., Thompson, N.L., Cissel, D.S., Obberghen-Schilling, E., Baker, C.C., Kass, M.E., Ellingsworth, L.R., Roberts, A.B. and Sporn, M.B., Transforming growth factor-β1: Histochemical localization with antibodies to different epitopes, J. Cell Biol., 108 (1989) 653-660.
19. [19] Fort, P., Marty, L., Piechaczyk, M., el Sabrouty, S., Dani, C., Jeanteur, P. and Blanchard, J.M., Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family, Nucleic Acids Res., 13 (1985) 1431-1442.
20. [20] Fowlis, D.J., Flanders, K.C., Duffie, E., Balmain, A. and Akhurst, R.J., Discordant transforming growth factor β1 RNA and protein localization during chemical carcinogenesis of the skin, Cell Growth Differ., 3 (1992) 81-91.
21. [21] Freese, A., Finklestine, S.P. and DiFiglia, M., Basic fibroblast growth factor protects striatal neurons in vitro from NMDA-receptor mediated excitotoxicity, Brain Res., 575 (1992) 351-355.
22. [22] Ginsberg, M.D. and Busto, R., Rodent models of cerebral ischemia, Stroke, 20 (1989) 1627-1642.
23. [23] Gross, C.E., Bednar, M.M., Howard, D.B. and Sporn, M.B., Transforming growth factor-β1 reduces infarct size after experimental cerebral ischemia in a rabbit model, Stroke, 24 (1993) 558-562.
24. [24] Hanks, S.K., Armour, R., Baldwin, J.H., Maldonado, F., Spiess, J. and Holley, R.W., Amino acid sequence of the BSC-1 cell growth inhibitor (polyergin) deduced from the nucleotide sequence of the cDNA, Proc. Natl. Acad. Sci. USA, 85 (1988) 79-82.
25. [25] Horn, M. and Schlote, W., Delayed neuronal death and delayed neuronal recovery in the human brain following global ischemia, Acta Neuropathol., 85 (1992) 79-87.
26. [26] Huang, Z., Huang, P.L., Panahian, N., Dalkara, T., Fishman, M.C. and Moskowitz, M.A., Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase, Science, 265 (1994) 1883-1885.
27. [27] Hunter, K.E., Sporn, M.B. and Davies, A.M., Transforming growth factor-betas inhibit mitogen-stimulated proliferation of astrocytes, Glia, 7 (1993) 203-211.
28. [28] Johanson, C.E., Tissue barriers: Diffusion, bulk flow and volume transmission of proteins and peptides within the brain. In: K.L. Audus and T.J. Raub (Eds.). Pharmaceutical Biotechnology. Vol. 5. Biological Barriers to Protein Delivery, Plenum Publ., New York, 1993, pp. 467-486.
29. [29] Klempt, N.D., Sirimanne, E., Gunn, A.J., Klempt, M., Singh, K., Williams, C. and Gluckman, P.D., Hypoxia-ischemia induces transforming growth factor beta 1 mRNA in the infant rat brain, Mol. Brain Res., 13 (1992) 93-101.
30. [30] Knuckey, N., Finch, P., Thompson, N., Palm, D., Primiano, M., Johanson, C., Flanders, K. and Sporn, M. The pattern of neuronal expression and the neuroprotective role of transforming growth factor beta isoforms following transient cerebral ischemia, FASEB J., 8 (1994) A654.
31. [31] Knuckey, N.W., Palm, D.E., Primiano, M.J., Epstein, M.H. and Johanson, C.E. N-Acetylcysteine enhances hippocampal neuronal survival after transient forebrain ischemia in rats, Stroke, 26 (1995) 305-316.
32. [32] Kogure, K. and Kato, H., Altered gene expression in cerebral ischemia, Stroke, 24 (1993) 2121-2127.
33. [33] Koketsu, N., Berlove, D.J., Moskowitz, M.A., Kowall, N.W., Caday, C.G. and Finklestein, S.P., Pretreatment with intraventricular basic fibroblast growth factor decreases infarct size following focal cerebral ischemia in rats, Ann. Neurol., 35 (1994) 451-457.
34. [34] Koliatsos, V.E., Nauta, H.J., Clatterbuck, R.E., Holtzman, D.M., Mobley, W.C. and Price, D.L., Mouse nerve growth factor prevents degeneration of axotomized basal forebrain cholinergic neurons in the monkey, J. Neurosci., 10 (1990) 3801-3813.
35. [35] Kromer, L.F., Nerve growth factor treatment after brain injury prevents neuronal death, Science, 235 (1987) 214-216.
36. [36] Lefebvre, P.P., Staecker, H., Weber, T., Van De Water, T.R., Rogister, B. and Moonen, G., TGF_beta 1 modulates bFGF receptor message expression in cultured adult auditory neurons, NeuroReport, 2 (1991) 305-308.
37. [37] Lindholm, D., Castren, E., Kiefer, R., Zafra, F. and Thoenen, H., Transforming growth factor-beta 1 in the rat brain: increase after injury and inhibition of astrocyte proliferation, J. Cell Biol., 117 (1992) 395-400.
38. [38] Logan, A., CNS growth factors, Br. J. Hosp. Med., 43 (1990) 428-437.
39. [39] Logan, A., Frautschy, S.A., Gonzalez, A.-M., Sporn, M.B. and Baird, A., Enhanced expression of transforming growth factor β1 in the rat brain after a localized cerebral injury. Brain Res., 587 (1992) 216-225.
40. [40] Maiese, K., Boniece, I., DeMeo, D. and Wager, J.A., Peptide growth factors protect against ischemia in culture by preventing nitric oxide toxicity, J. Neurosci., 13 (1993) 3034-3040.
41. [41] Marmarou, J.A. anderson, R.L., Ward, J.D., Choi, S.C., Young, H.F., Eisenberg, H.M., Foulkes, M.A., Marshall, L.F. and Jane, J.A., Impact of ICP instability and hypotension on outcome in patients with severe head trauma, J. Neurosurg., 75 (1991) S59-S66.
42. [42] Mattson, M.P., Murrain, M., Guthrie, P.B. and Kater, S.B., Fibroblast growth factor and glutamate: opposing roles in the generation and degeneration of hippocampal neuroarchitecure, J. Neurosci., 9 (1989) 3728-3740.
43. [43] McNeill, H., Williams, C., Guan, J., Dragunow, M., Lawlor, P., Sirimanne, E., Nikolics, K. and Gluckman, P., Neuronal rescue with transforming growth factor-β1 after hypoxic-ischaemic brain injury, NeuroReport, 5 (1994) 901-904.
44. [44] Morganti-Kossmann, M.C., Kossmann, T., Brandes, M.E., Mergenhagen, S.E. and Wahl, S.M., Autocrine and paracrine regulation of astrocyte function by transforming growth factor-β, J. Neuroimmunol., 39 (1992) 163-173.
45. [45] Morioka, T., Kalehua, A.N. and Streit, W.J., The microglial reaction in the rat hippocampus following transient forebrain ischemia, J. Cereb. Blood Flow Metab., 11 (1991) 966-973.
46. [46] Nakata, N., Kato, H. and Kogure, K., Protective effects of basic fibroblast growth factor against hippocampal neuronal damage following cerebral ischemia in the gerbil. Brain Res., 605 (1993) 354-356.
47. [47] Palm, D., Knuckey, N., Guglielmo, M., Watson, P., Primiano, M. and Johanson, C., Choroid plexus electrolytes and ultrastructure following transient forebrain ischemia. Am. J. Physiol. 269 (1995) R73-R79.
48. [48] Palm, D.E., Knuckey, N.W., Primiano, M.J., Spangenberger, A.G. and Johanson, C.E., Cystatin C, a protease inhibitor, in degenerating rat hippocampal neurons following transient forebrain ischemia. Brain Res., 691 (1995) 1-8.
49. [49] Pelton, R.W., Dickinson, M.E., Moses, H.L. and Hogan, B.L.M., In situ hybridization analysis of TGFβ3 RNA expression during mouse development: comparative studies with TGFβ1 and β2, Development, 110 (1990) 609-620.
50. [50] Plouet, J. and Gospodarowicz, D., Transforming growth factor Beta-1 positively modulates the bioactivity of fibroblast growth factor on corneal endothelial cells. J. Cell. Physiol., 141 (1989) 392-399.
51. [51] Prehn, J.H.M., Backhaus, C. and Krieglstein, J., Transforming growth factor-β1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse neocortex from ischemic injury in vivo, J. Cereb. Blood Flow Metab., 13 (1993) 521-525.
52. [52] Prehn J.H.M., Peruche, B., Unsicker, K. and Krieglstein, J., Isoform-specific effects of transforming growth factors-β on degeneration of primary neuronal cultures induced by cytotoxic hypoxia or glutamate, J. Neurochem., 60 (1993) 1665-1672.
53. [53] Prehn, J.H.M., Bindokas, V.P., Marcuccilli, C.J., Krajewski, S., Reed, J.C. and Miller, R.J., Regulation of neuronal Bcl2 protein expression and calcium homeostasis by transforming growth factor type β confers wide-ranging protection on rat hippocampal neurons, Proc. Natl. Acad. Sci. USA, 91 (1994) 12599-12603.
54. [54] Qian, S.W., Kondaiah, P., Roberts, A.B. and Sporn, M.B., cDNA cloning by PCR of rat transforming growth factor-β1, Nucl. Acids Res., 18 (1990) 3059.
55. [55] Roberts, A.B., Kim, S.J., Kondaiah, P., Jakowlew, S.B., Denhez, F., Glick, A.B., Geiser, A.C., Watanabe, S., Noma, T., Lechleider, R. and Sporn, M.B., Transcriptional control of expression of the TGF-βs, Ann. NY Acad. Sci., 593 (1990) 43-50.
56. [56] Roberts A.B. and Sporn, M.B., Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta), Growth Factors, 8 (1993) 1-9.
57. [57] Roberts, A.B., Vodovotz, Y., Roche, N.S., Sporn, M.B. and Nathan, C.F., Role of nitric oxide in antagonistic effects of transforming growth factor-β and interleukin-1 beta on the beating rate of cultured cardiac myocytes, Mol. Endocrinol., 6 (1992) 1921-1930.
58. [58] Roine, R.O., Kajaste, S. and Kaste, M., Neuropsychological sequelae of cardiac arrest. JAMA, 269 (1993) 237-242.
59. [59] Ryken, T.C., Traynelis, V.C. and Lim, R., Interaction of acidic fibroblast growth factor and transforming growth factor-β in normal and transformed glia in vitro, J. Neurosurg., 76 (1992) 850-855.
60. [60] Seubert, P., Lee, K. and Lynch, G., Ischemia triggers NMDA receptor-linked cytoskeletal proteolysis in hippocampus, Brain Res., 492 (1989) 366-370.
61. [61] Shigeno, T., Mina, T., Takakura, K., Graham, D.I., Kato, G., Hashimoto, Y. and Furukawa, S., Amelioration of delayed neuronal death in the hippocampus by nerve growth factor, J. Neurosci., 11 (1991) 2914-2919.
62. [62] Smith, M.-L., Auer, R.N. and Siesjo, B.K., The density and distribution of ischemic brain injury in the rat following 2-10 min of forebrain ischemia, Acta Neuropathol., 64 (1984) 319-332.
63. [63] Solem, M., Rawson, C., Lindburg, K. and Barnes, D. Transforming growth factor beta regulates cystatin C in serum-free mouse embryo (SFME) cells. Biochem. Biophys. Res. Commun., 172 (1990) 945-951.
64. [64] Suzumura, A., Sawada, M., Yamamoto, H. and Marunouchi, T., Transforming growth factor-β suppresses activation and proliferation of microglia in vitro, J. Immunol., 151 (1993) 2150-2158.
65. [65] Thompson, N.L., Flanders, K.C., Smith, J.M., Ellingsworth, L.R., Roberts, A.B. and Sporn, M.B., Expression of transforming growth factor-β1 in specific cells and tissues of adult and neonatal mice, J. Cell Biol., 108 (1989) 661-669.
66. [66] Unsicker, K., Flanders, K.C., Cissel, D.S., Lafyatis, R. and Sporn, M.B., Transforming growth factor beta isoforms in the adult rat central and peripheral nervous system., Neuroscience, 44 (1991) 613-625.
67. [67] Walicke, P.A., Novel neurotrophic factors, receptors, and oncogenes, Annu. Rev. Neurosci., 12 (1989) 103-126.
68. [68] Zafra, F., Lindholm, D., Castren, E., Hartikka, J. and Thoenen, H., Regulation of brain-derived neurotrophic factor and nerve growth factor mRNA in primary cultures of hippocampal neurons and astrocytes, J. Neurosci., 12 (1992) 4793-4799.
69. [69] Zola-Morgan, S., Squire, L.R. and Amaral, D.G., Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus, J. Neurosci., 6 (1986) 2950-2967.